More about

Atherosclerotic Cardiovascular Disease

News
September 27, 2023
2 min read
Save

Climbing more than five flights of stairs daily may lower heart disease risk by 20%

Climbing more than five flights of stairs daily may lower heart disease risk by 20%

Adults who reported climbing more than five flights of stairs daily were 20% less likely to develop atherosclerotic CVD over 12 years compared with those who reported never climbing stairs, according to data from a UK Biobank analysis.

News
September 13, 2023
2 min read
Save

Evinacumab reduces atherogenic lipoproteins in patients with refractory hyperlipidemia

Evinacumab reduces atherogenic lipoproteins in patients with refractory hyperlipidemia

The fully monoclonal angiopoietin-like 3 antibody evinacumab conferred sustained, long-term reductions in LDL and other atherogenic lipoproteins among patients with refractory hyperlipidemia, researchers reported.

News
August 23, 2023
3 min read
Save

Mehran: Underdiagnosis of peripheral artery disease in women ‘daunting and unacceptable’

Mehran: Underdiagnosis of peripheral artery disease in women ‘daunting and unacceptable’

DANA POINT, Calif. — Peripheral artery disease remains underdiagnosed and undertreated among women worldwide and efforts are needed to increase awareness, improve diagnoses and ensure patient referrals, according to a speaker.

News
July 25, 2023
3 min read
Save

Beyond type 2 diabetes, metformin may also offer heart benefits

Beyond type 2 diabetes, metformin may also offer heart benefits

ARLINGTON, Texas — Experimental and clinical evidence suggest the diabetes drug metformin may offer CV benefits that do not depend on the presence of diabetes, and an ongoing trial will help researchers learn more, according to a speaker.

News
July 11, 2023
3 min read
Save

Veterans with CVD from historically redlined neighborhoods have elevated risk for events

Veterans with CVD from historically redlined neighborhoods have elevated risk for events

Among veterans with atherosclerotic CVD, those from historically redlined neighborhoods had greater risk for CV events compared with those from the lowest-risk neighborhoods, researchers reported.

News
June 20, 2023
2 min read
Save

FDA approves CV version of colchicine for patients with residual inflammatory risk

FDA approves CV version of colchicine for patients with residual inflammatory risk

Agepha Pharma announced that the FDA approved a 0.5 mg dose of colchicine for reduction of CV events in patients with atherosclerotic CVD or multiple CV risk factors who have residual inflammatory risk.

News
June 09, 2023
3 min read
Save

CAC screening, follow-up care lacking among Black patients in small study

CAC screening, follow-up care lacking among Black patients in small study

Black patients who undergo coronary artery calcium scoring received less post-screening care and had more adverse CV events compared with white patients at a single center, a speaker reported.

News
June 08, 2023
3 min read
Save

Heart in Diabetes conference will spotlight latest research in cardiometabolic care

Heart in Diabetes conference will spotlight latest research in cardiometabolic care

Leading experts from cardiorenal metabolic specialties will present the latest research with clinical implications for diabetes, CVD and kidney disease, with a new format this year designed to drive multispecialty discussions.

News
June 08, 2023
6 min read
Save

Addressing disparities in ASCVD within the US South Asian population

Addressing disparities in ASCVD within the US South Asian population

The South Asian population in the U.S. is one of the fastest-growing minority ethnic groups, and these individuals are a particularly higher-risk population.

News
June 02, 2023
2 min read
Save

Semaglutide may reduce risk for atherosclerotic CVD among adults with obesity

Semaglutide may reduce risk for atherosclerotic CVD among adults with obesity

Adults with obesity who used semaglutide for weight loss reduced their 10-year risk for atherosclerotic cardiovascular disease, according to findings presented at the European Congress on Obesity.

View more